Search...
MYL: Subsidiary obtains drug registration certificate
MYL announced that its subsidiary Jiangxi MYL Meikang Pharmaceutical Co., Ltd. has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops issued by the National Medical Products Administration. Olopatadine Hydrochloride Eye Drops are used to treat eye itching associated with allergic conjunctivitis
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments